HLA Diagnostics 05 – High resolution, molecular HLA typing class I and II (444)
[HLA-Diagnostik 05 - Hochauflösende, molekulargenetische HLA-Typisierung Klasse I und II (444)]
EPTIS Ringversuch Nr. 160009 | Letze Änderung 2023-10-23 | URL: https://www.eptis.bam.de/pts160009 https://www.eptis.bam.de/pts160009
| Name des Anbieters | |||||||||||||||||||||||||||||||||||||
| Name des Anbieters | INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories | ||||||||||||||||||||||||||||||||||||
| Ansässig in | Germany | ||||||||||||||||||||||||||||||||||||
| Sprache(n) | German, English | ||||||||||||||||||||||||||||||||||||
| Anmerkungen | The interdisciplinary, non-profit, scientific and medical association INSTAND e. V. is a reference institution for the quality control of medical laboratories. It is one of three reference institutions appointed by the German Medical Association and, thus, responsible for the organization of external quality assessment (EQA) schemes for quality control in medical laboratories. You can register for EQAs, submit your results as PDF via https://rv-online.instandev.de. This price applies exclusively to orders placed via INSTAND e.V. Prices and services may differ for orders placed via distributors. | ||||||||||||||||||||||||||||||||||||
| Klassifizierung | |||||||||||||||||||||||||||||||||||||
| Produktgruppen |
Human test material
|
||||||||||||||||||||||||||||||||||||
| Prüfgebiete |
Medical analysis
|
||||||||||||||||||||||||||||||||||||
| Technische Einzelheiten | |||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
| Ringversuchsziele | |||||||||||||||||||||||||||||||||||||
| Zielgruppe des Ringversuchs | Molecular HLA typing class I and II in high resolution according to standards of the European Federation for Immunogenetics (EFI). The following loci may be reported: HLA-A,-B,-C,-DRB1,-DRB3/4/5,-DQA1,- DQB1,-DPA1 and -DPB1. In addition, HLA-B*57:01 associated with Abacavir hypersensitivity and HLA-DR epitopes associated with rheumatoid arthritis may be reported. It is not possible to report individual antigens, e.g. in the context of HLA disease associations (HLA-A29, HLA-B51, etc.) | ||||||||||||||||||||||||||||||||||||
| Relevante Rechtsvorschriften oder Normen | |||||||||||||||||||||||||||||||||||||
| Weitere Ziele | |||||||||||||||||||||||||||||||||||||
| Teilnehmerzahl | <50 | ||||||||||||||||||||||||||||||||||||
| Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt) |
Akkreditiert durch DAkkS (Germany) auf der Grundlage von ISO/IEC 17043 German Bundesärztekammer (General medical Council) |
||||||||||||||||||||||||||||||||||||
| Die Durchführung des Ringversuchs ist in Auftrag gegeben durch | German Bundesärztekammer (General medical Council) | ||||||||||||||||||||||||||||||||||||
| Kosten | |||||||||||||||||||||||||||||||||||||
| Teilnahmegebühr | 140 Euro | ||||||||||||||||||||||||||||||||||||
| Regelmässig durchgeführt | Ja (4 times per year) | ||||||||||||||||||||||||||||||||||||
| Der Ringversuch wird durchgeführt seit | Experience with operation of ILCs since 1968 | ||||||||||||||||||||||||||||||||||||
| Kontaktdaten des Anbieters | |||||||||||||||||||||||||||||||||||||
| Anbieter | Kontaktperson | ||||||||||||||||||||||||||||||||||||
|
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
P.O.Box 250211, Ubierstrasse 20 40223 Düsseldorf Germany Telefon: +49-211-159213-0 Fax: Web: http://www.instandev.de/ http://www.instandev.de/ |
Dr. rer. nat. Nathalie Weiss
Telefon: +49-211-159213430 Fax: E-Mail: weiss@instand-ev.de weiss@instand-ev.de |
||||||||||||||||||||||||||||||||||||